As filed with the Securities and Exchange Commission on May 20, 2005.
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May 20, 2005 (May 19, 2005)
MEDAREX, INC.
(Exact name of registrant as specified in its charter)
New Jersey |
|
0-19312 |
|
22-2822175 |
(State of other
jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
(Address of Principal Executive Offices)
Registrants telephone number, including area code: (609) 430-2880
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Agreement.
On May 19, 2005, the shareholders of Medarex, Inc. approved the 2005 Equity Incentive Plan, a copy of which is incorporated by reference into this Current Report on Form 8-K.
Item 5.02. Election of Directors.
On May 19, 2005, the shareholders of Medarex, Inc. elected Dr. Patricia M. Danzon and Mr. Michael A. Appelbaum to serve as directors for three-year terms ending at the 2008 annual meeting of shareholders. Additional information on Mr. Appelbaum and Dr. Danzon is set forth in the Medarex Proxy Statement filed with the Securities and Exchange Commission on April 8, 2005.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:
Exhibit |
|
|
|
|
|
99.1 |
|
Medarex, Inc. 2005 Equity Incentive Plan, incorporated by reference to Appendix B to Medarex, Inc.s Proxy Statement filed with the SEC on April 8, 2005. (File No. 000-19312). |
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
MEDAREX, INC. |
|||
|
|
Registrant |
|||
|
|
|
|||
|
|
|
|||
Date: May 20, 2005 |
|
|
By: |
/s/ Christian S. Schade |
|
|
|
|
Christian S. Schade |
||
|
|
|
Senior Vice President and |
||
|
|
|
Chief Financial Officer |
4
EXHIBIT INDEX
Exhibit |
|
Description |
|
|
|
|
|
|
|
99.1 |
|
Medarex, Inc. 2005 Equity Incentive Plan, incorporated by reference to Appendix B to Medarex, Inc.s Proxy Statement filed with the SEC on April 8, 2005. (File No. 000-19312). |
|
|
5